| pubmed-article:19339317 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19339317 | lifeskim:mentions | umls-concept:C0025344 | lld:lifeskim |
| pubmed-article:19339317 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19339317 | lifeskim:mentions | umls-concept:C0038661 | lld:lifeskim |
| pubmed-article:19339317 | lifeskim:mentions | umls-concept:C0150369 | lld:lifeskim |
| pubmed-article:19339317 | lifeskim:mentions | umls-concept:C0011570 | lld:lifeskim |
| pubmed-article:19339317 | lifeskim:mentions | umls-concept:C0557854 | lld:lifeskim |
| pubmed-article:19339317 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:19339317 | pubmed:dateCreated | 2009-4-2 | lld:pubmed |
| pubmed-article:19339317 | pubmed:abstractText | Department of Veterans Affairs (VA) patients in depression treatment have high suicide rates after psychiatric hospitalization, antidepressant starts, and dosage changes. Policy makers have recommended closer monitoring during these periods to reduce suicide. This study assessed the frequency of high-risk periods in clinical settings, the levels of monitoring provided during these periods, and the estimated costs of providing monitoring consistent with the most stringent Food and Drug Administration recommendation for treatment periods after antidepressant change (seven visits in the first 12 weeks). | lld:pubmed |
| pubmed-article:19339317 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19339317 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19339317 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19339317 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19339317 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19339317 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19339317 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19339317 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:19339317 | pubmed:issn | 1557-9700 | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:EisenbergDani... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:OlfsonMarkM | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:KimHyungjin... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:BlowFrederic... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:ValensteinMar... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:McCarthyJohn... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:PietteJohn... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:GanoczyDaraD | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:AustinKaren... | lld:pubmed |
| pubmed-article:19339317 | pubmed:author | pubmed-author:ZivinKaraK | lld:pubmed |
| pubmed-article:19339317 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19339317 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:19339317 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19339317 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19339317 | pubmed:pagination | 439-44 | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:meshHeading | pubmed-meshheading:19339317... | lld:pubmed |
| pubmed-article:19339317 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19339317 | pubmed:articleTitle | Service implications of providing intensive monitoring during high-risk periods for suicide among VA patients with depression. | lld:pubmed |
| pubmed-article:19339317 | pubmed:affiliation | Health Services Research and Development, Department of Veterans Affairs Medical Center, 2215 Fuller Rd., Box 130170, Ann Arbor, MI 48113-0170, USA. marciav@med.umich.edu | lld:pubmed |
| pubmed-article:19339317 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19339317 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:19339317 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19339317 | lld:pubmed |
